Evidence map›Paper›PMID 19452510›Full record

ArticleMolecular carcinogenesis2009

The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) mice.

Sara E Meyer, Susan E Waltz, Kathleen H Goss

Abstract read
In one paragraph

Article in Molecular carcinogenesis, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Ron receptor tyrosine kinase signaling as a therapeutic target.Expert opinion on therapeutic targets · 2012
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sara E MeyerDepartment of Cancer and Cell Biology, University of Cincinnati, Cincinnati, Ohio, USA.
Susan E Waltz
Kathleen H Goss
University of Cincinnati · USUniversity of Chicago · US

Funding

REGULATION OF CELLULAR GROWTH AND DIFFERENTIATIONT32CA059268 · NCI · UNIVERSITY OF CINCINNATI · PI KHAN, SOHAIB A. · 1993 to 2010
$2.3M
The Ron Receptor in Mammary Gland BiologyR01CA100002 · NCI · UNIVERSITY OF CINCINNATI · PI WALTZ, SUSAN E · 2004 to 2008
$1.5M
The Ron Receptor/Chemokine Axis in Prostate CancerR01CA125379 · NCI · UNIVERSITY OF CINCINNATI · PI WALTZ, SUSAN E · 2008 to 2012
$1.3M
NCI NIH HHS CA 100002NCI NIH HHS R01 CA100002NCI NIH HHS R01 CA125379NCI NIH HHS T32 CA059268NCI NIH HHS T32 CA 59268
6 · The paper itself

Abstract

The Ron receptor tyrosine kinase is overexpressed in approximately half of all human colon cancers. Increased Ron expression positively correlates with tumor progression, and reduction of Ron levels in human colon adenocarcinoma cells reverses their tumorigenic properties. Nearly all colon tumors demonstrate loss of the adenomatous polyposis coli (APC) tumor suppressor, an early initiating event, subsequently leading to beta-catenin stabilization. To understand the role of Ron in early stage intestinal tumorigenesis, we generated Apc-mutant (Apc(Min/+)) mice with and without Ron signaling. Interestingly, we report here that significantly more Apc(Min/+) Ron-deficient mice developed higher tumor burden than Apc(Min/+) mice with wild-type Ron. Even though baseline levels of intestinal crypt proliferation were increased in the Apc(Min/+) Ron-deficient mice, loss of Ron did not influence tumor size or histological appearance of the Apc(Min/+) adenomas, nor was beta-catenin localization changed compared to Apc(Min/+) mice with Ron. Together, these data suggest that Ron may be important in normal intestinal tissue homeostasis, but that the expression of this receptor is not required for the formation and growth of adenomas in Apc(Min/+) mice.

Indexed as

AdenomaAnimalsBase SequenceCell ProliferationColonic NeoplasmsDNA PrimersImmunohistochemistryMiceMice, Inbred C57BLMice, Mutant StrainsPolymerase Chain ReactionReceptor Protein-Tyrosine KinasesDNA PrimersReceptor Protein-Tyrosine KinasesRON protein

Identifiers

PMID19452510
PMCPMC4102426
OpenAlexW2000925949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.